-
1
-
-
78649320661
-
Translating novel strategies for cardioprotection: the hatter workshop recommendations
-
PID: 20865418
-
Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, et al. Translating novel strategies for cardioprotection: the hatter workshop recommendations. Basic Res Cardiol. 2010;105(6):677–86.
-
(2010)
Basic Res Cardiol
, vol.105
, Issue.6
, pp. 677-686
-
-
Hausenloy, D.J.1
Baxter, G.2
Bell, R.3
Botker, H.E.4
Davidson, S.M.5
Downey, J.6
-
2
-
-
84873126984
-
ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines
-
O'Gara PT, Kushner FG, Ascheim DD, Casey Jr DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2012. doi:10.1161/CIR.0b013e3182742cf6.
-
(2013)
Circulation
, pp. 2012
-
-
O'Gara, P.T.1
Kushner, F.G.2
Ascheim, D.D.3
Casey, D.E.4
Chung, M.K.5
de Lemos, J.A.6
-
3
-
-
84866732231
-
ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
-
COI: 1:CAS:528:DC%2BC38XhsFektbrE, PID: 22922416
-
Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619. doi:10.1093/eurheartj/ehs215.
-
(2012)
Eur Heart J
, vol.33
, Issue.20
, pp. 2569-2619
-
-
Steg, P.G.1
James, S.K.2
Atar, D.3
Badano, L.P.4
Blomstrom-Lundqvist, C.5
Borger, M.A.6
-
4
-
-
84918506276
-
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines
-
PID: 25085962
-
Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;130(24):2215–45. doi:10.1161/CIR.0000000000000105.
-
(2014)
Circulation
, vol.130
, Issue.24
, pp. 2215-2245
-
-
Fleisher, L.A.1
Fleischmann, K.E.2
Auerbach, A.D.3
Barnason, S.A.4
Beckman, J.A.5
Bozkurt, B.6
-
5
-
-
34447571672
-
Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms
-
COI: 1:CAS:528:DC%2BD2sXotVWrtLY%3D, PID: 17643594
-
Merla R, Daher IN, Ye Y, Uretsky BF, Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J. 2007;154(2):391–402. doi:10.1016/j.ahj.2007.04.029.
-
(2007)
Am Heart J
, vol.154
, Issue.2
, pp. 391-402
-
-
Merla, R.1
Daher, I.N.2
Ye, Y.3
Uretsky, B.F.4
Birnbaum, Y.5
-
6
-
-
84856158305
-
ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC)
-
PID: 21873419
-
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC). Eur Heart J. 2011;32(23):2999–3054. doi:10.1093/eurheartj/ehr236.
-
(2011)
Eur Heart J
, vol.32
, Issue.23
, pp. 2999-3054
-
-
Hamm, C.W.1
Bassand, J.P.2
Agewall, S.3
Bax, J.4
Boersma, E.5
Bueno, H.6
-
7
-
-
84905585676
-
Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR substudy)
-
COI: 1:CAS:528:DC%2BC2cXhtFWgtrrO, PID: 24994545
-
Fuernau G, Eitel I, Wohrle J, Kerber S, Lauer B, Pauschinger M, et al. Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR substudy). Am J Cardiol. 2014;114(4):503–9. doi:10.1016/j.amjcard.2014.05.026.
-
(2014)
Am J Cardiol
, vol.114
, Issue.4
, pp. 503-509
-
-
Fuernau, G.1
Eitel, I.2
Wohrle, J.3
Kerber, S.4
Lauer, B.5
Pauschinger, M.6
-
8
-
-
84902254150
-
Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY study)
-
COI: 1:CAS:528:DC%2BC2cXnvFSqtrw%3D, PID: 24831577
-
Ko YG, Won H, Shin DH, Kim JS, Kim BK, Choi D, et al. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY study). Am J Cardiol. 2014;114(1):29–35. doi:10.1016/j.amjcard.2014.03.059.
-
(2014)
Am J Cardiol
, vol.114
, Issue.1
, pp. 29-35
-
-
Ko, Y.G.1
Won, H.2
Shin, D.H.3
Kim, J.S.4
Kim, B.K.5
Choi, D.6
-
9
-
-
84867900547
-
Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial
-
PID: 22419603
-
Post S, Post MC, van den Branden BJ, Eefting FD, Goumans MJ, Stella PR, et al. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. Catheter Cardiovasc Interv. 2012;80(5):756–65. doi:10.1002/ccd.23449.
-
(2012)
Catheter Cardiovasc Interv
, vol.80
, Issue.5
, pp. 756-765
-
-
Post, S.1
Post, M.C.2
van den Branden, B.J.3
Eefting, F.D.4
Goumans, M.J.5
Stella, P.R.6
-
10
-
-
82555189918
-
Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
-
COI: 1:CAS:528:DC%2BC3MXhsFyns73I, PID: 22137076
-
Hahn JY, Kim HJ, Choi YJ, Jo SH, Kim HJ, Lee S, et al. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 2011;162(6):1026–33. doi:10.1016/j.ahj.2011.08.011.
-
(2011)
Am Heart J
, vol.162
, Issue.6
, pp. 1026-1033
-
-
Hahn, J.Y.1
Kim, H.J.2
Choi, Y.J.3
Jo, S.H.4
Kim, H.J.5
Lee, S.6
-
11
-
-
78549281829
-
Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes
-
PID: 21076721
-
Sun Y, Qi G, Gao Y, Zhang H, Pang X, Zhao W, et al. Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes. Can J Cardiol. 2010;26(9):481–5.
-
(2010)
Can J Cardiol
, vol.26
, Issue.9
, pp. 481-485
-
-
Sun, Y.1
Qi, G.2
Gao, Y.3
Zhang, H.4
Pang, X.5
Zhao, W.6
-
12
-
-
84890123674
-
Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials
-
PID: 24038054
-
Liu Y, Su Q, Li L. Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials. Clin Cardiol. 2013;36(12):E41–8. doi:10.1002/clc.22198.
-
(2013)
Clin Cardiol
, vol.36
, Issue.12
, pp. E41-E48
-
-
Liu, Y.1
Su, Q.2
Li, L.3
-
13
-
-
67651033611
-
Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial
-
PID: 19643320
-
Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial. J Am Coll Cardiol. 2009;54(6):558–65. doi:10.1016/j.jacc.2009.05.028.
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.6
, pp. 558-565
-
-
Di Sciascio, G.1
Patti, G.2
Pasceri, V.3
Gaspardone, A.4
Colonna, G.5
Montinaro, A.6
-
14
-
-
84899973037
-
Preloading with atorvastatin before percutaneous coronary intervention in statin-naive Asian patients with non-ST elevation acute coronary syndromes: a randomized study
-
PID: 24216317
-
Jang Y, Zhu J, Ge J, Kim YJ, Ji C, Lam W. Preloading with atorvastatin before percutaneous coronary intervention in statin-naive Asian patients with non-ST elevation acute coronary syndromes: a randomized study. J Cardiol. 2014;63(5):335–43. doi:10.1016/j.jjcc.2013.09.012.
-
(2014)
J Cardiol
, vol.63
, Issue.5
, pp. 335-343
-
-
Jang, Y.1
Zhu, J.2
Ge, J.3
Kim, Y.J.4
Ji, C.5
Lam, W.6
-
15
-
-
84896690579
-
Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial Infarction?
-
COI: 1:CAS:528:DC%2BC2cXjt12rt7Y%3D, PID: 23952289
-
Nafasi L, Rahmani R, Shafiee A, Salari A, Abdollahi A, Meysamie A. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial Infarction? Curr Med Res Opin. 2014;30(3):381–6. doi:10.1185/03007995.2013.834249.
-
(2014)
Curr Med Res Opin
, vol.30
, Issue.3
, pp. 381-386
-
-
Nafasi, L.1
Rahmani, R.2
Shafiee, A.3
Salari, A.4
Abdollahi, A.5
Meysamie, A.6
-
16
-
-
0033826581
-
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
-
COI: 1:CAS:528:DC%2BD3cXmslSjsL0%3D, PID: 10973320
-
Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000;6(9):1004–10. doi:10.1038/79510.
-
(2000)
Nat Med
, vol.6
, Issue.9
, pp. 1004-1010
-
-
Kureishi, Y.1
Luo, Z.2
Shiojima, I.3
Bialik, A.4
Fulton, D.5
Lefer, D.J.6
-
17
-
-
34548421559
-
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation
-
COI: 1:CAS:528:DC%2BD2sXhtVOqtrnI, PID: 17616749
-
Merla R, Ye Y, Lin Y, Manickavasagam S, Huang MH, Perez-Polo RJ, et al. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol. 2007;293(3):H1918–28. doi:10.1152/ajpheart.00416.2007.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.293
, Issue.3
, pp. H1918-H1928
-
-
Merla, R.1
Ye, Y.2
Lin, Y.3
Manickavasagam, S.4
Huang, M.H.5
Perez-Polo, R.J.6
-
18
-
-
34447524076
-
Kitakaze M, Perez-polo JR. Mechanism of myocardial protection by atorvastatin: 5'-nucleotidase is upstream of eNOS activation
-
Birnbaum Y, Ye Y, Lin Y, Uretsky BF. Kitakaze M, Perez-polo JR. Mechanism of myocardial protection by atorvastatin: 5'-nucleotidase is upstream of eNOS activation. Circ Res. 2006;99:E26.
-
(2006)
Circ Res
, vol.99
, pp. E26
-
-
Birnbaum, Y.1
Ye, Y.2
Lin, Y.3
Uretsky, B.F.4
-
19
-
-
20844443811
-
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase
-
COI: 1:CAS:528:DC%2BD2cXotFGks70%3D, PID: 15451788
-
Sanada S, Asanuma H, Minamino T, Node K, Takashima S, Okuda H, et al. Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation. 2004;110(15):2143–9. doi:10.1161/01.CIR.0000143830.59419.73.
-
(2004)
Circulation
, vol.110
, Issue.15
, pp. 2143-2149
-
-
Sanada, S.1
Asanuma, H.2
Minamino, T.3
Node, K.4
Takashima, S.5
Okuda, H.6
-
20
-
-
48349147462
-
Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat
-
COI: 1:CAS:528:DC%2BD1cXovV2gsb8%3D, PID: 18327703
-
Ye Y, Abu Said GH, Lin Y, Manickavasagam S, Hughes MG, McAdoo DJ, et al. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther. 2008;22(4):275–82. doi:10.1007/s10557-008-6105-z.
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, Issue.4
, pp. 275-282
-
-
Ye, Y.1
Abu Said, G.H.2
Lin, Y.3
Manickavasagam, S.4
Hughes, M.G.5
McAdoo, D.J.6
-
21
-
-
3142749673
-
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging)
-
PID: 14522503
-
Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol. 2003;42(7):1318–33.
-
(2003)
J Am Coll Cardiol
, vol.42
, Issue.7
, pp. 1318-1333
-
-
Klocke, F.J.1
Baird, M.G.2
Lorell, B.H.3
Bateman, T.M.4
Messer, J.V.5
Berman, D.S.6
-
22
-
-
0024424802
-
Caffeine reduces dipyridamole-induced myocardial ischemia
-
COI: 1:STN:280:DyaK3c%2FhtFenuw%3D%3D, PID: 2795213
-
Smits P, Aengevaeren WR, Corstens FH, Thien T. Caffeine reduces dipyridamole-induced myocardial ischemia. J Nucl Med. 1989;30(10):1723–6.
-
(1989)
J Nucl Med
, vol.30
, Issue.10
, pp. 1723-1726
-
-
Smits, P.1
Aengevaeren, W.R.2
Corstens, F.H.3
Thien, T.4
-
23
-
-
0025938257
-
False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion
-
COI: 1:STN:280:DyaK3Mzjt1Ojsw%3D%3D, PID: 1869975
-
Smits P, Corstens FH, Aengevaeren WR, Wackers FJ, Thien T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med. 1991;32(8):1538–41.
-
(1991)
J Nucl Med
, vol.32
, Issue.8
, pp. 1538-1541
-
-
Smits, P.1
Corstens, F.H.2
Aengevaeren, W.R.3
Wackers, F.J.4
Thien, T.5
-
24
-
-
34447499108
-
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination
-
COI: 1:CAS:528:DC%2BD2sXovVyht7o%3D, PID: 17416607
-
Ye Y, Lin Y, Perez-Polo R, Huang MH, Hughes MG, McAdoo DJ, et al. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol. 2007;293(1):H813–8. doi:10.1152/ajpheart.00210.2007.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.293
, Issue.1
, pp. H813-H818
-
-
Ye, Y.1
Lin, Y.2
Perez-Polo, R.3
Huang, M.H.4
Hughes, M.G.5
McAdoo, D.J.6
-
25
-
-
79958699276
-
Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin
-
COI: 1:CAS:528:DC%2BC3MXivVOmsb0%3D, PID: 20640495
-
Ye Y, Long B, Qian J, Perez-Polo JR, Birnbaum Y. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin. Cardiovasc Drugs Ther. 2010;24(5–6):391–9. doi:10.1007/s10557-010-6252-x.
-
(2010)
Cardiovasc Drugs Ther
, vol.24
, Issue.5-6
, pp. 391-399
-
-
Ye, Y.1
Long, B.2
Qian, J.3
Perez-Polo, J.R.4
Birnbaum, Y.5
-
26
-
-
35348975175
-
The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation
-
COI: 1:CAS:528:DC%2BD2sXhtF2itbbP, PID: 17620005
-
Manickavasagam S, Ye Y, Lin Y, Perez-Polo RJ, Huang MH, Lui CY, et al. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. Cardiovasc Drugs Ther. 2007;21(5):321–30. doi:10.1007/s10557-007-6036-0.
-
(2007)
Cardiovasc Drugs Ther
, vol.21
, Issue.5
, pp. 321-330
-
-
Manickavasagam, S.1
Ye, Y.2
Lin, Y.3
Perez-Polo, R.J.4
Huang, M.H.5
Lui, C.Y.6
-
27
-
-
84906936926
-
Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect
-
COI: 1:CAS:528:DC%2BC2cXhtl2hsb3M, PID: 25012137
-
Nanhwan MK, Ling S, Kodakandla M, Nylander S, Ye Y, Birnbaum Y. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect. Arterioscler Thromb Vasc Biol. 2014;34(9):2078–85. doi:10.1161/ATVBAHA.114.304002.
-
(2014)
Arterioscler Thromb Vasc Biol
, vol.34
, Issue.9
, pp. 2078-2085
-
-
Nanhwan, M.K.1
Ling, S.2
Kodakandla, M.3
Nylander, S.4
Ye, Y.5
Birnbaum, Y.6
-
28
-
-
84938074255
-
Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction
-
Ye Y, Birnbaum GD, Perez-Polo JR, Nanhwan MK, Nylander S, Birnbaum Y. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol. 2015. doi:10.1161/ATVBAHA.115.305655.
-
(2015)
Arterioscler Thromb Vasc Biol
-
-
Ye, Y.1
Birnbaum, G.D.2
Perez-Polo, J.R.3
Nanhwan, M.K.4
Nylander, S.5
Birnbaum, Y.6
-
29
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
COI: 1:CAS:528:DC%2BD1MXhtFaltL%2FJ, PID: 19717846
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57. doi:10.1056/NEJMoa0904327.
-
(2009)
N Engl J Med
, vol.361
, Issue.11
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
-
30
-
-
81855224663
-
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American college of cardiology foundation endorsed by the world heart federation and the preventive cardiovascular nurses association
-
Smith Jr SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American college of cardiology foundation endorsed by the world heart federation and the preventive cardiovascular nurses association. J Am Coll Cardiol. 2011;58(23):2432–46. doi:10.1016/j.jacc.2011.10.824.
-
(2011)
J Am Coll Cardiol
, vol.58
, Issue.23
, pp. 2432-2446
-
-
Smith, S.C.1
Benjamin, E.J.2
Bonow, R.O.3
Braun, L.T.4
Creager, M.A.5
Franklin, B.A.6
-
31
-
-
33646403165
-
Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2
-
COI: 1:CAS:528:DC%2BD28XkvFSmsbc%3D, PID: 16339820
-
Atar S, Ye Y, Lin Y, Freeberg SY, Nishi SP, Rosanio S, et al. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol. 2006;290(5):H1960–8. doi:10.1152/ajpheart.01137.2005.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.290
, Issue.5
, pp. H1960-H1968
-
-
Atar, S.1
Ye, Y.2
Lin, Y.3
Freeberg, S.Y.4
Nishi, S.P.5
Rosanio, S.6
-
32
-
-
34447511271
-
Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin
-
COI: 1:CAS:528:DC%2BD2sXmvF2ksr4%3D, PID: 17277020
-
Birnbaum Y, Lin Y, Ye Y, Martinez JD, Huang MH, Lui CY, et al. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. Am J Physiol Heart Circ Physiol. 2007;292(6):H2891–7. doi:10.1152/ajpheart.01269.2006.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, Issue.6
, pp. H2891-H2897
-
-
Birnbaum, Y.1
Lin, Y.2
Ye, Y.3
Martinez, J.D.4
Huang, M.H.5
Lui, C.Y.6
-
33
-
-
84861230309
-
Pleiotropic effects of statins: the role of eicosanoid production
-
COI: 1:CAS:528:DC%2BC38XkvVOmsLs%3D, PID: 22286195
-
Birnbaum Y, Ye Y. Pleiotropic effects of statins: the role of eicosanoid production. Curr Atheroscler Rep. 2012;14(2):135–9. doi:10.1007/s11883-012-0232-5.
-
(2012)
Curr Atheroscler Rep
, vol.14
, Issue.2
, pp. 135-139
-
-
Birnbaum, Y.1
Ye, Y.2
-
34
-
-
11444251238
-
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury
-
COI: 1:CAS:528:DC%2BD2MXitVamtg%3D%3D, PID: 15639473
-
Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu ZY, Schwarz ER, et al. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res. 2005;65(2):345–55. doi:10.1016/j.cardiores.2004.10.018.
-
(2005)
Cardiovasc Res
, vol.65
, Issue.2
, pp. 345-355
-
-
Birnbaum, Y.1
Ye, Y.2
Rosanio, S.3
Tavackoli, S.4
Hu, Z.Y.5
Schwarz, E.R.6
-
35
-
-
84881611663
-
Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes
-
COI: 1:CAS:528:DC%2BC3sXptFGgsLg%3D, PID: 23751937
-
Berger JS. Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes. Am J Cardiol. 2013;112(5):737–45. doi:10.1016/j.amjcard.2013.04.055.
-
(2013)
Am J Cardiol
, vol.112
, Issue.5
, pp. 737-745
-
-
Berger, J.S.1
-
36
-
-
80051550924
-
Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial
-
COI: 1:CAS:528:DC%2BC3MXpslGisrc%3D, PID: 21709065
-
Mahaffey KW, Wojdyla DM, Carroll K, Becker RC, Storey RF, Angiolillo DJ, et al. Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial. Circulation. 2011;124(5):544–54. doi:10.1161/CIRCULATIONAHA.111.047498.
-
(2011)
Circulation
, vol.124
, Issue.5
, pp. 544-554
-
-
Mahaffey, K.W.1
Wojdyla, D.M.2
Carroll, K.3
Becker, R.C.4
Storey, R.F.5
Angiolillo, D.J.6
-
37
-
-
84856702326
-
The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury
-
COI: 1:CAS:528:DC%2BC3MXhsFOnsL7L, PID: 21892746
-
Ye Y, Perez-Polo JR, Aguilar D, Birnbaum Y. The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury. Basic Res Cardiol. 2011;106(6):925–52. doi:10.1007/s00395-011-0216-6.
-
(2011)
Basic Res Cardiol
, vol.106
, Issue.6
, pp. 925-952
-
-
Ye, Y.1
Perez-Polo, J.R.2
Aguilar, D.3
Birnbaum, Y.4
-
38
-
-
4344588402
-
Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels
-
PID: 15201621
-
Tavackoli S, Ashitkov T, Hu ZY, Motamedi M, Uretsky BF, Birnbaum Y. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels. Coron Artery Dis. 2004;15(1):53–8.
-
(2004)
Coron Artery Dis
, vol.15
, Issue.1
, pp. 53-58
-
-
Tavackoli, S.1
Ashitkov, T.2
Hu, Z.Y.3
Motamedi, M.4
Uretsky, B.F.5
Birnbaum, Y.6
-
39
-
-
78149267940
-
Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions
-
COI: 1:CAS:528:DC%2BC3cXhsVymtb3L, PID: 20955429
-
Ye Y, Perez-Polo JR, Birnbaum Y. Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions. Ann N Y Acad Sci. 2010;1207:76–82. doi:10.1111/j.1749-6632.2010.05725.x.
-
(2010)
Ann N Y Acad Sci
, vol.1207
, pp. 76-82
-
-
Ye, Y.1
Perez-Polo, J.R.2
Birnbaum, Y.3
-
40
-
-
55949098646
-
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone
-
COI: 1:CAS:528:DC%2BD1cXhtlGhsb%2FK, PID: 18825491
-
Ye Y, Lin Y, Perez-Polo JR, Birnbaum Y. Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone. Cardiovasc Drugs Ther. 2008;22(6):429–36. doi:10.1007/s10557-008-6138-3.
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, Issue.6
, pp. 429-436
-
-
Ye, Y.1
Lin, Y.2
Perez-Polo, J.R.3
Birnbaum, Y.4
-
41
-
-
33748368084
-
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
-
COI: 1:CAS:528:DC%2BD28XhtVSksrjO, PID: 16603698
-
Ye Y, Lin Y, Atar S, Huang MH, Perez-Polo JR, Uretsky BF, et al. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol. 2006;291(3):H1158–69. doi:10.1152/ajpheart.00096.2006.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.291
, Issue.3
, pp. H1158-H1169
-
-
Ye, Y.1
Lin, Y.2
Atar, S.3
Huang, M.H.4
Perez-Polo, J.R.5
Uretsky, B.F.6
-
42
-
-
84869804106
-
Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms
-
COI: 1:CAS:528:DC%2BC38Xhs12isr3M, PID: 22985024
-
Birnbaum Y, Ye Y, Bajaj M. Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012;10(6):387–90. doi:10.1089/met.2012.0095.
-
(2012)
Metab Syndr Relat Disord
, vol.10
, Issue.6
, pp. 387-390
-
-
Birnbaum, Y.1
Ye, Y.2
Bajaj, M.3
-
43
-
-
84860807487
-
Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia
-
PID: 22496084
-
Lonborg J, Kelbaek H, Vejlstrup N, Botker HE, Kim WY, Holmvang L, et al. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circ Cardiovasc Interv. 2012;5(2):288–95. doi:10.1161/CIRCINTERVENTIONS.112.968388.
-
(2012)
Circ Cardiovasc Interv
, vol.5
, Issue.2
, pp. 288-295
-
-
Lonborg, J.1
Kelbaek, H.2
Vejlstrup, N.3
Botker, H.E.4
Kim, W.Y.5
Holmvang, L.6
-
44
-
-
84867521142
-
Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction
-
PID: 23067912
-
Lonborg J, Schoos MM, Kelbaek H, Holmvang L, Steinmetz J, Vejlstrup N, et al. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction. Am Heart J. 2012;164(4):538–46. doi:10.1016/j.ahj.2012.07.021.
-
(2012)
Am Heart J
, vol.164
, Issue.4
, pp. 538-546
-
-
Lonborg, J.1
Schoos, M.M.2
Kelbaek, H.3
Holmvang, L.4
Steinmetz, J.5
Vejlstrup, N.6
-
45
-
-
84883295202
-
Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study
-
COI: 1:CAS:528:DC%2BC3sXht1OqsbfE, PID: 23868944
-
Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, et al. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol. 2013;33(9):2252–60. doi:10.1161/ATVBAHA.113.301586.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, Issue.9
, pp. 2252-2260
-
-
Woo, J.S.1
Kim, W.2
Ha, S.J.3
Kim, J.B.4
Kim, S.J.5
Kim, W.S.6
-
46
-
-
84883765959
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
-
COI: 1:CAS:528:DC%2BC3sXhsF2ksbzN, PID: 23992601
-
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317–26. doi:10.1056/NEJMoa1307684.
-
(2013)
N Engl J Med
, vol.369
, Issue.14
, pp. 1317-1326
-
-
Scirica, B.M.1
Bhatt, D.L.2
Braunwald, E.3
Steg, P.G.4
Davidson, J.5
Hirshberg, B.6
-
47
-
-
84883745765
-
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
-
COI: 1:CAS:528:DC%2BC3sXhsF2ksbzP, PID: 23992602
-
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369(14):1327–35. doi:10.1056/NEJMoa1305889.
-
(2013)
N Engl J Med
, vol.369
, Issue.14
, pp. 1327-1335
-
-
White, W.B.1
Cannon, C.P.2
Heller, S.R.3
Nissen, S.E.4
Bergenstal, R.M.5
Bakris, G.L.6
-
48
-
-
77951812608
-
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
-
COI: 1:CAS:528:DC%2BC3cXmt1Kmurk%3D, PID: 20207816
-
Ye Y, Keyes KT, Zhang C, Perez-Polo JR, Lin Y, Birnbaum Y. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA. Am J Physiol Heart Circ Physiol. 2010;298(5):H1454–65. doi:10.1152/ajpheart.00867.2009.
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.298
, Issue.5
, pp. H1454-H1465
-
-
Ye, Y.1
Keyes, K.T.2
Zhang, C.3
Perez-Polo, J.R.4
Lin, Y.5
Birnbaum, Y.6
-
49
-
-
0035058592
-
Opioids and cardioprotection
-
COI: 1:CAS:528:DC%2BD3MXislGquro%3D, PID: 11316516
-
Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89(2):123–37.
-
(2001)
Pharmacol Ther
, vol.89
, Issue.2
, pp. 123-137
-
-
Schultz, J.E.1
Gross, G.J.2
-
50
-
-
40149096222
-
Morphine postconditioning protects against reperfusion injury in the isolated rat hearts
-
COI: 1:CAS:528:DC%2BD1cXjtVeqt7c%3D, PID: 18155248
-
Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res. 2008;145(2):287–94. doi:10.1016/j.jss.2007.07.020.
-
(2008)
J Surg Res
, vol.145
, Issue.2
, pp. 287-294
-
-
Chen, Z.1
Li, T.2
Zhang, B.3
-
51
-
-
80051777068
-
Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts
-
COI: 1:CAS:528:DC%2BC3MXhtFaiu7%2FL, PID: 21860754
-
Kim JH, Chun KJ, Park YH, Kim J, Kim JS, Jang YH, et al. Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts. Korean J Anesthesiol. 2011;61(1):69–74. doi:10.4097/kjae.2011.61.1.69.
-
(2011)
Korean J Anesthesiol
, vol.61
, Issue.1
, pp. 69-74
-
-
Kim, J.H.1
Chun, K.J.2
Park, Y.H.3
Kim, J.4
Kim, J.S.5
Jang, Y.H.6
-
52
-
-
84940447272
-
Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging
-
de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Urban D, et al. Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol. 2015. doi:10.1007/s00392-015-0835-2.
-
(2015)
Clin Res Cardiol
-
-
de Waha, S.1
Eitel, I.2
Desch, S.3
Fuernau, G.4
Lurz, P.5
Urban, D.6
-
53
-
-
0026042355
-
Gastric emptying and small bowel transit in male volunteers after i.m. ketorolac and morphine
-
COI: 1:STN:280:DyaK38%2FjtVKgug%3D%3D, PID: 1931399
-
Yee MK, Evans WD, Facey PE, Hayward MW, Rosen M. Gastric emptying and small bowel transit in male volunteers after i.m. ketorolac and morphine. Br J Anaesth. 1991;67(4):426–31.
-
(1991)
Br J Anaesth
, vol.67
, Issue.4
, pp. 426-431
-
-
Yee, M.K.1
Evans, W.D.2
Facey, P.E.3
Hayward, M.W.4
Rosen, M.5
-
54
-
-
84932134291
-
Acetaminophen absorption kinetics in altered gastric emptying: establishing a relevant pharmacokinetic surrogate using published data
-
PID: 26095480
-
Srinivas NR. Acetaminophen absorption kinetics in altered gastric emptying: establishing a relevant pharmacokinetic surrogate using published data. J Pain Palliat Care Pharmacother. 2015;29(2):115–9. doi:10.3109/15360288.2015.1035834.
-
(2015)
J Pain Palliat Care Pharmacother
, vol.29
, Issue.2
, pp. 115-119
-
-
Srinivas, N.R.1
-
55
-
-
84907048411
-
Prehospital ticagrelor in ST-segment elevation myocardial infarction
-
Montalescot G, Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014. doi:10.1056/NEJMoa1407024.
-
(2014)
N Engl J Med
-
-
Montalescot, G.1
Hof, A.W.2
Lapostolle, F.3
Silvain, J.4
Lassen, J.F.5
Bolognese, L.6
-
56
-
-
84885022162
-
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial
-
COI: 1:CAS:528:DC%2BC3sXhsFOksbvP, PID: 24002794
-
Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A, et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation. 2013;128(14):1495–503. doi:10.1161/CIRCULATIONAHA.113.003653.
-
(2013)
Circulation
, vol.128
, Issue.14
, pp. 1495-1503
-
-
Ibanez, B.1
Macaya, C.2
Sanchez-Brunete, V.3
Pizarro, G.4
Fernandez-Friera, L.5
Mateos, A.6
|